VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 76 filers reported holding VAXCYTE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $107,934,000 | +5.2% | 4,254,390 | -6.7% | 1.07% | +46.2% |
| Q2 2021 | $102,611,000 | +14.0% | 4,558,475 | 0.0% | 0.73% | -30.4% |
| Q1 2021 | $90,030,000 | -31.4% | 4,558,475 | -7.7% | 1.05% | -27.8% |
| Q4 2020 | $131,288,000 | -48.4% | 4,941,213 | -4.2% | 1.46% | -68.1% |
| Q3 2020 | $254,631,000 | +56.2% | 5,156,553 | 0.0% | 4.56% | +58.5% |
| Q2 2020 | $162,999,000 | – | 5,156,553 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
| Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
| RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
| COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
| GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
| ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
| Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
| Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
| BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |